- Home
- AMRC vs QURE Comparison
AMRC vs QURE Comparison
Compare AMRC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRC
- QURE
- Stock Information
- Founded
- AMRC 2000
- QURE 1998
- Country
- AMRC United States
- QURE Netherlands
- Employees
- AMRC N/A
- QURE N/A
- Industry
- AMRC Engineering & Construction
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- AMRC Consumer Discretionary
- QURE Health Care
- Exchange
- AMRC Nasdaq
- QURE Nasdaq
- Market Cap
- AMRC 2.2B
- QURE 1.9B
- IPO Year
- AMRC 2010
- QURE 2007
- Fundamental
- Price
- AMRC $33.59
- QURE $27.66
- Analyst Decision
- AMRC Buy
- QURE Strong Buy
- Analyst Count
- AMRC 9
- QURE 13
- Target Price
- AMRC $31.33
- QURE $62.33
- AVG Volume (30 Days)
- AMRC 525.7K
- QURE 4.7M
- Earning Date
- AMRC 11-03-2025
- QURE 11-10-2025
- Dividend Yield
- AMRC N/A
- QURE N/A
- EPS Growth
- AMRC 18.87
- QURE N/A
- EPS
- AMRC 1.19
- QURE N/A
- Revenue
- AMRC $1,883,767,000.00
- QURE $15,751,000.00
- Revenue This Year
- AMRC $10.00
- QURE N/A
- Revenue Next Year
- AMRC $9.50
- QURE $229.18
- P/E Ratio
- AMRC $27.36
- QURE N/A
- Revenue Growth
- AMRC 12.22
- QURE N/A
- 52 Week Low
- AMRC $8.49
- QURE $5.85
- 52 Week High
- AMRC $44.93
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- AMRC 46.55
- QURE 33.96
- Support Level
- AMRC $29.75
- QURE $26.20
- Resistance Level
- AMRC $32.79
- QURE $29.99
- Average True Range (ATR)
- AMRC 2.05
- QURE 2.87
- MACD
- AMRC -0.24
- QURE -0.33
- Stochastic Oscillator
- AMRC 46.35
- QURE 39.18
About AMRC Ameresco Inc.
Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.